Noorani T
The University of Auckland, Auckland, New Zealand.
ArticlePsychedelics
Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design.
ArticlePsilocybin
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.
ArticleLSD
Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.
PreprintPsychedelics
The Psychedelic Media Exposure Questionnaire: The development and validation of a new scale assessing psychedelic-related media exposure
PreprintPsilocybin
Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms
PreprintPsilocybin
Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms
ArticlePsychedelics
On Minimizing Risk and Harm in the Use of Psychedelics.
PreprintPsilocybin
Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms
PreprintPsilocybin
Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms
ArticlePsychedelics
Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials.
ArticlePsilocybin
Psychedelic Identity Shift: A Critical Approach to Set And Setting.
ArticlePsychedelics